Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability—a randomized, placebo-controlled, 3-month trial-Reference-Cited by-同舟云学术

Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability—a randomized, placebo-controlled, 3-month trial

Published:2003-08 Issue:6 Volume:4 Page:307-315
ISSN:1526-5900
Container-title:The Journal of Pain
language:en
Short-container-title:The Journal of Pain

Author:

Birbara Charles A,Puopolo Anthony D,Munoz David R,Sheldon Eric A,Mangione Antoinette,Bohidar Norman R,Geba Gregory P

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,Neurology

Reference37 articles.

1. The Quebec task force classification for spinal disorders and the severity, treatment, and outcomes of sciatic and lumbar spinal stenosis;Atlas;Spine,1996

2. Minimally clinical important difference;Bombardier;J Rheumatol,2000

3. Chronic low back pain;Borenstein;Rheum Dis Clin North Am,1996

4. COX-2 inhibitors and renal failure;Boyd;Med J Aust,2000

5. Renal effects of COX-2 selective inhibitors;Brater;Am J Nephrol,2001

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of success of pharmacological management in patients with chronic lower back pain: systematic review;Journal of Orthopaedic Surgery and Research;2024-04-18

2. The Efficacy and Safety of a Combination of Thiocolchicoside and Etoricoxib in Low Back Pain (ESCoTEL): A Randomized Active-Controlled Trial;Cureus;2023-10-25

3. A Systematic Review on NSAID and Tanezumab efficacy in Chronic Lower Back Pain;2023-09-22

4. Between guidelines and clinical trials: evidence-based advice on the pharmacological management of non-specific chronic low back pain;BMC Musculoskeletal Disorders;2023-05-30

5. Benefits and harms of treatments for chronic nonspecific low back pain without radiculopathy: systematic review and meta-analysis;The Spine Journal;2023-05